Cylene Pharmaceuticals, Inc.
Records under this name other than patents Cylene Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Cylene Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,816,406 | Quinolone analogs Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,816,524 | Methods of preparing quinolone analogs Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,062,043 | Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,910,600 | Therapeutic kinase modulators Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,853,234 | Quinolone analogs and methods related thereto Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,928,100 | Quinolone analogs and methods related thereto Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,956,064 | Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,367,681 | Pyrazolopyrimidines and related heterocycles as kinase inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,303,033 | Pyrazolopyrimidines and related heterocycles as CK2 inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,575,177 | Pyrazolopyrimidines and related heterocycles as CK2 inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record |